A vaccine to combat COVID-19 was discovered through global scientific collaboration and manufactured within less than a year. However, the logistics of global production and the global delivery of the vaccine has faced many challenges and the emerging vaccine nationalism belies the rallying call of the WHO viz. “none of us will be safe until everyone is safe”. In turn, this raises the question: Should there be a new supranational institution that oversees the governance of global production and distribution or are the existing WTO/TRIPS (World Trade Organisation/ Trade-Related Aspects of Intellectual Property Rights) institutions good enough?
The invited speakers will offer different perspectives about the risks stemming from vaccine nationalism and how they can be overcome, which we want to use as a starting point for scholarly debate on the likely role for a supranational organisation.
Key areas that we will explore are:
- How did globalisation contribute positively to the development and manufacturing of the Covid-19 vaccine?
- To what extent and why did global cooperation fail in the administration phase of the vaccine?
- Is there an emerging role for a new supranational organisation?
- Are there useful lessons to learn from the governance of global climate change?
- What are the implications for the future of global value chains and the future of travel?
This is not an exhaustive list and as before we look forward to insights from the audience.
Book you place now via Eventbrite
You will be sent a link to join this event via email when you book your place.
- Grazia Ietto-Gillies, Emeritus Professor of Applied Economics, London South Bank University and Visiting Professor Birkbeck University of London
- Klaus Meyer Professor of International Business, Ivey Business School, Western University, in London, Ontario
If you have any queries please contact Dearnna Clinkscales at email@example.com